Quotient invests in radiolabelled services
Quotient Bioresearch has agreed to acquire Amersham Radiolabelling Services and construct a new facility, expanding its radiochemical synthesis, testing and clinical studies offering.
Caraco products seized by FDA
US Marshals have seized products from Caraco’s facilities in Michigan because of concerns over cGMP compliance, which has led to Sun Pharma withdrawing its financial guidance.
KBI rolls out PER.C6 service in US
US contract services firm KBI Biopharma has begun using the PER.C6 platform for cell line generation as part of its offering to meet growing demand for biomanufacturing services.
OctoPlus’ trial materials plant open for business
Dutch biopharmaceuticals producer OctoPlus has begun manufacturing operations at its new facility in Leiden, the Netherlands.
KV completes investigation; admits deficiencies
KV Pharmaceutical found deficiencies and instances of noncompliance during its internal investigation, which was launched in response to issues with the FDA and allegations of management misconduct.
Sanyo claims H202 steralised incubator is industry first
Sanyo Biomedical and Environmental Solutions claims the H202 steralisation approach used by its Steisonic CxP MCO-19AIC(UVH) cell incubator system is an industry first and effective replacement for ethylene oxide (EtO).
Azopharma expands cytotoxics capacity
US contractor Azopharma has added new GMP quality cytotoxics and high-potency manufacturing capacity at its facility in Hollywood, South Florida in a bid to strengthen its position in the trial materials sector.
Sigpack says rotational toploader a revolution for vial handling
Sigpack Systems, a subsidiary of Bosch Packaging Technology, claims its new toploader unit will both improve the efficiency and cut the cost of handling delicate pharmaceutical packaging.
AMRI completes Budapest facility
AMRI (Albany Molecular Research, Inc) has completed construction of its R&D facility in Budapest, Hungary, which forms part of the company’s goal of transforming its European operations.
Norwich’s developmental expansion continues
Norwich is continuing to diversify and expand its offering by adding pilot scale production and capacity to develop high potency compounds.
Millipore’s Massachusetts Mobius plant open for business
Millipore has ramped up capacity for its Mobius range of single use bio-processing and manufacturing technologies with a new purpose built production facility in Danvers, Massachusetts.
Vetter expands secondary packaging capacity
German aseptic filling specialist Vetter has boosted packaging operations at its new facility in Ravensburg to meet growing demand for cost-effective secondary packaging services
Lonza’s GS system wins Elusys anthrax Ab contract
Swiss life sciences solutions firm Lonza has been contracted by US biotechnology group Elusys Therapeutics to produce Anthim, its late stage Ab candidate treatment for anthrax infection.
Patheon’s Q2 on track despite fall in demand
Contractor Patheon’s financial recovery is going well despite the current downturn in the outsourcing market, according to CEO Wes Wheeler.
Sanofi uses SCM for radiolabelled production
Sanofi-Aventis is using SCM Pharma’s aseptic fill/finish service for radiolabelled compounds to manufacture an oncology product that is in clinical trials.